Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Nitto Denko Corporation has announced the signing of a partnership agreement with global pharmaceutical company Daiichi Sankyo Company, Ltd. that will utilize Nitto's proprietary PassPort® active transdermal drug delivery technology.
read more
Nitto Denko Avecia announced the opening of its new oligonucleotide API manufacturing facility in Milford, MA.
read more
Wednesday, October 12, 2016
Nitto Denko Avecia Inc. has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals, both located in Irvine, CA.
read more
Thursday, September 03, 2020
MD Logistics and MD Express (collectively, MDL) have been acquired by Nippon Express U.S.A., (NEU), a U.S. based subsidiary of Nippon Express.
read more
Nippon Express has obtained Good Distribution Practice certification, effective Monday, March 29, 2021, for its Shanghai Pudong Airport CFS.
read more
Wednesday, April 11, 2012
As more and more R&D is outsourced by pharmaceutical companies, a study released today provides new insight into how to structure the relevant partnerships for success.
read more
The NIIMBL announces that they have received $8.9 million from the U.S. Department of Commerce's NIST.
read more
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) has contributed biopharmaceutical manufacturing ontologies to The Open Applications Group (OAGi) for further development as an open-source project. Shifting NIIMBL's ...
read more
The National Institutes of Health has awarded $12.7 million to match nine academic research groups with a selection of pharmaceutical industry compounds to explore new treatments for patients in eight disease areas, including Alzheimer’s disease, ...
read more
Thursday, August 17, 2023
The National Institutes of Health (NIH), the US’s medical research agency, selected Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO) specialized in gene therapy, vaccines, oncolytic viruses, and nucleic acid-...
read more
NightHawk Biosciences announced that its Scorpion subsidiary recently opened its San Antonio facility.
read more
Tuesday, October 10, 2017
Nicox and pSivida announced their an agreement to explore the potential of combining Nicox's nitric oxide (NO)-donating compounds with pSivida's bioerodible sustained release drug delivery system.
read more
Idifarma’s GMP spray drying technology for highly potent drugs up to Category 4 OEL/OEB is now operational.
read more
Nexus Pharmaceuticals announced an agreement with the village of Pleasant Prairie, Wisconsin to build a sterile injectable manufacturing facility.
read more
Nexus Pharmaceuticals announced that its pharmaceutical manufacturing facility in Pleasant Prairie, Wisconsin, was successfully inspected by the FDA, which will allow Nexus to begin commercial operations.
read more